RESTATEMENT OF PRIOR FINANCIAL STATEMENTS (Details 1) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
|
| Research and Development | $ 442,340 | $ 1,294,921 | $ 1,557,010 | $ 3,307,716 |
| Total Costs and Expenses | 1,705,830 | 5,538,811 | ||
| Loss from operations | (1,705,830) | (5,538,811) | ||
| Net Loss | $ (1,584,339) | $ (3,502,755) | $ (5,648,968) | $ (7,212,568) |
| Basic and diluted loss per share | $ (0.17) | $ (0.81) | ||
| As Reported [Member] | ||||
| Research and Development | $ 792,439 | $ 1,907,109 | ||
| Total Costs and Expenses | 2,055,929 | 5,888,910 | ||
| Loss from operations | (2,055,929) | (5,888,910) | ||
| Net Loss | $ (1,934,438) | $ (5,999,067) | ||
| Basic and diluted loss per share | $ (0.21) | $ (0.86) | ||
| Adjustment [Member] | ||||
| Research and Development | $ 350,099 | $ 350,099 | ||
| Total Costs and Expenses | (350,099) | (350,099) | ||
| Loss from operations | 350,099 | 350,099 | ||
| Net Loss | $ 350,099 | $ 350,099 | ||
| Basic and diluted loss per share | $ 0.04 | $ 0.05 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|